Highlights Epithelial ovarian cancer (EOC) is the fourth leading cause of cancer-related deaths among women. The study aimed to evaluate the efficacy and toxicity of external beam radiotherapy (RT) for isolated recurrent epithelial ovarian cancer. RT showed significant antitumor effect against isolated recurrent EOC without causing severe toxicities.
This week’s “JOURNAL WATCH” discusses a clinical trial “Radiotherapy for isolated recurrent epithelial ovarian cancer: A single institutional experience” published in ‘The Journal of Obstetrics and Gynecology research, 2019’ . Authors: Naoko Komura1, Seiji Mabuchi1, Fumiaki Isohashi2, Eriko Yokoi1, Kotaro Shimura1, Yuri Matsumoto1, Michiko Kodama1, Takuji Tomimatsu1, Kazuhiko Ogawa2, and Tadashi Kimura1 What was the need for this study? Epithelial ovarian cancer is a fatal disease in women as it is diagnosed at stage III or IV in most of…
